Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Kantakari (Solanum xanthocarpum) is an Ayurvedic respiratory herb containing alkaloids like solanine and carpesterol that provide bronchodilatory effects. The plant's saponins and glycoalkaloids reduce airway inflammation while stimulating immune cell activity through enhanced phagocytosis.
Reported Benefits (Provisional)
Origin & History
Kantakari, also known as Yellow-berried Nightshade, is a spiny shrub native to India. It is harvested for its medicinal properties and used in various Ayurvedic formulations.
Research Narrative (Provisional)
Some studies suggest Kantakari may help alleviate respiratory issues due to its anti-inflammatory properties. However, more rigorous clinical trials are needed.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
{"macronutrients": {"fiber": "3.5g per 100g", "protein": "1.2g per 100g"}, "micronutrients": {"vitamin C": "12mg per 100g", "calcium": "20mg per 100g", "iron": "1.5mg per 100g"}, "bioactive_compounds": {"solasodine": "0.5% of dry weight", "saponins": "2.1% of dry weight", "flavonoids": "0.8% of dry weight"}, "bioavailability_notes": "The bioavailability of solasodine and saponins may be enhanced by cooking or processing, while vitamin C content may decrease with heat exposure."}
Reported Mechanism (Provisional)
Kantakari's alkaloids including solanine and carpesterol act as natural bronchodilators by relaxing smooth muscle in the respiratory tract and inhibiting inflammatory mediators like histamine. The herb's saponins enhance immune function by stimulating macrophage activity and increasing white blood cell phagocytosis. Its bitter compounds stimulate gastric acid production through vagal nerve activation, improving digestive enzyme secretion.
Clinical Narrative (Provisional)
Limited clinical research exists for kantakari, with most evidence coming from traditional use and preliminary animal studies. Small-scale human trials (n=30-50) have shown modest improvements in respiratory symptoms and bronchial function, but larger controlled studies are needed. Animal research demonstrates significant anti-inflammatory effects at doses of 200-400mg/kg, but human equivalent dosing remains uncertain. The current evidence is promising but insufficient to make definitive therapeutic claims.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.